CWMS
UTHR icon

CFG Wealth Management Services’s United Therapeutics UTHR Stock Holding History

CFG Wealth Management Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-113
Closed -$67K – 142
2026
Q1 		$67K Buy
+113
New +$56.3K 0.06% 89

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

CFG Wealth Management Services's UTHR Position: Q2 2026 in Review

CFG Wealth Management Services sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 113 shares — an estimated $67K sold.

CFG Wealth Management Services first reported a position in UTHR in Q1 2026 and held it in 1 quarter. The position peaked at $67K in Q1 2026. 873 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • CFG Wealth Management Services reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • CFG Wealth Management Services sold 113 United Therapeutics shares in Q2 2026, an estimated $67K.
  • CFG Wealth Management Services first reported a position in United Therapeutics in Q1 2026 and held it in 1 quarter.
  • CFG Wealth Management Services's United Therapeutics position peaked at $67K in Q1 2026.
  • 873 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on CFG Wealth Management Services's 13F filing for Q2 2026, filed 15 Jul 2026.